Relationship between drug-related problems and health outcomes: A cross-sectional study among cardiovascular patients

Pharmacy World and Science

Volumn 32, Issue 4, 2010, Pages 512-519

  Niquille, Anne ^a   Bugnon, Olivier ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Collaborative pharmacy practice; Community pharmacy; Drug costs; Drug related problems; Medication review; Quality of life; Switzerland

Indexed keywords

ALLOPURINOL; ANTIDIABETIC AGENT; ATORVASTATIN; DIGOXIN; PRAVASTATIN; SARTAN DERIVATIVE; SIMVASTATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG SUBSTITUTION; DYSLIPIDEMIA; ECONOMIC ASPECT; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT DEPARTMENT; PHARMACIST; PILOT STUDY; POPULATION RESEARCH; QUALITY OF LIFE; SWITZERLAND; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUG UTILIZATION REVIEW; FEMALE; GENERAL PRACTITIONERS; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; QUALITY OF LIFE; SWITZERLAND;

EID: 77956419537     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9401-1     Document Type: Article

References (27)

1. CD Hepler LM Strand 1990 Opportunities and responsibilities in pharmaceutical care Am J Hosp Pharm 47 533 543 1:STN:280:DyaK3c7ps1Sgsw%3D%3D 2316538
2. JW van Mil M Schulz TF Tromp 2004 Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review Pharm World Sci 26 303 311 10.1007/s11096-004-2849-0 15683098
3. M Machado J Bajcar GC Guzzo TR Einarson 2007 Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management Ann Pharmacother 41 1569 1582 10.1345/aph.1K151 17712043 (Pubitemid 47479786)
4. M Machado J Bajcar GC Guzzo TR Einarson 2007 Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management Ann Pharmacother 41 1770 1781 10.1345/aph.1K311 17925496 (Pubitemid 350044338)
5. M Machado N Nassor JM Bajcar GC Guzzo TR Einarson 2008 Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management Ann Pharmacother 42 1195 1207 10.1345/aph.1K618 18682540
6. A Ponniah B Anderson S Shakib CJ Doecke M Angley 2007 Pharmacists' role in the post-discharge management of patients with heart failure: a literature review J Clin Pharm Ther 32 343 352 10.1111/j.1365-2710.2007.00827.x 1:STN:280:DC%2BD2svhvVKrug%3D%3D 17635336 (Pubitemid 47063157)
7. SL Koshman TL Charrois SH Simpson FA McAlister RT Tsuyuki 2008 Pharmacist care of patients with heart failure: a systematic review of randomized trials Arch Intern Med 168 687 694 10.1001/archinte.168.7.687 18413550 (Pubitemid 351563951)
8. A Blenkinsopp C Anderson M Armstrong 2003 Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease J Public Health 25 144 153 10.1093/pubmed/fdg030 (Pubitemid 36758777)
9. DP Wubben EM Vivian 2008 Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review Pharmacotherapy 28 421 436 10.1592/phco.28.4.421 18363526 (Pubitemid 351466454)
10. JT Hanlon CI Lindblad SL Gray 2004 Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2 3 13 10.1016/S1543-5946(04)90002-5 15555474 (Pubitemid 38559454)
11. S Royal L Smeaton AJ Avery B Hurwitz A Sheikh 2006 Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis Qual Saf Health Care 15 23 31 10.1136/qshc.2004.012153 1:STN:280:DC%2BD28%2FntV2ktg%3D%3D 16456206 (Pubitemid 43275522)
12. KK Viktil HS Blix 2008 The impact of clinical pharmacists on drug-related problems and clinical outcomes Basic Clin Pharmacol Toxicol 102 275 280 10.1111/j.1742-7843.2007.00206.x 1:CAS:528:DC%2BD1cXjt1Cmsb4%3D 18248511 (Pubitemid 351287571)
13. R Holland J Desborough L Goodyer S Hall D Wright YK Loke 2008 Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis Br J Clin Pharmacol 65 303 316 10.1111/j.1365-2125.2007.03071.x 18093253 (Pubitemid 351316922)
14. M Pirmohamed S James S Meakin C Green AK Scott TJ Walley, et al. 2004 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients BMJ 329 15 19 10.1136/bmj.329.7456.15 15231615 (Pubitemid 38869995)
15. S Schneeweiss J Hasford M Gottler A Hoffmann AK Riethling J Avorn 2002 Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study Eur J Clin Pharmacol 58 285 291 10.1007/s00228-002-0467-0 12136375 (Pubitemid 34827858)
16. T Mjorndal MD Boman S Hagg M Backstrom BE Wiholm A Wahlin, et al. 2002 Adverse drug reactions as a cause for admissions to a department of internal medicine Pharmacoepidemiol Drug Saf 11 65 72 10.1002/pds.667 11998554 (Pubitemid 34269600)
17. K Wester AK Jonsson O Spigset H Druid S Hagg 2008 Incidence of fatal adverse drug reactions: a population based study Br J Clin Pharmacol 65 573 579 10.1111/j.1365-2125.2007.03064.x 18070216 (Pubitemid 351365134)
18. P Craig P Dieppe S Macintyre S Michie I Nazareth M Petticrew 2008 Developing and evaluating complex interventions: the new Medical Research Council guidance BMJ 337 a1655 10.1136/bmj.a1655 18824488
19. JM Krahenbuhl A Decollogny O Bugnon 2008 Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program Pharm World Sci 30 6 816 822 10.1007/s11096-008-9232-5 18551382
20. R Horne J Clatworthy A Polmear J Weinman 2001 Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens 15 Suppl 1 S65 S68 11685914
21. Ware JE, Kosinski M, Turner-Bowker DM, Ganiats TG. How to score version 2 to the SF-12 health survey. Lincoln, RI: QualityMetric Inc.;2005. ISBN 1-897810-10-3.
22. The Pharmaceutical Care Network Europe Classification V6.2 (document on the Internet). 2010. http://www.pcne.org/Documents/DRP/ PCNE%20classification%20V6-2.pdf. Updated 14 Jan 2010, accessed 10 Mar 2010.
23. F Fernandez-Llimós M-J Faus MA Gastelurruita MI Baena L Tuneu F Martinez Martinez 2004 Systematic identification of negative clinical outcomes from pharmacotherapy Seguim Farmacoter 2 195 205
24. F Fernandez-Llimos MJ Faus 2004 Comment: drug-related problem classification systems Ann Pharmacother 38 1542 1543 15292502
25. JT Hanlon KE Schmader GP Samsa M Weinberger KM Uttech IK Lewis, et al. 1992 A method for assessing drug therapy appropriateness J Clin Epidemiol 45 1045 1051 10.1016/0895-4356(92)90144-C 1:STN:280:DyaK3s7hsFOnsw%3D%3D 1474400
26. A Niquille C Lattmann O Bugnon 2010 Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators Pharm Pract (Internet) 8 1 35 42
27. N Rodondi T Peng AJ Karter DC Bauer E Vittinghoff S Tang, et al. 2006 Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus Ann Intern Med 144 475 484 16585661